Literature DB >> 22190590

Nascent HDL formation in hepatocytes and role of ABCA1, ABCG1, and SR-BI.

Ailing Ji1, Joanne M Wroblewski1, Lei Cai1, Maria C de Beer2, Nancy R Webb1, Deneys R van der Westhuyzen3.   

Abstract

To study the mechanisms of hepatic HDL formation, we investigated the roles of ABCA1, ABCG1, and SR-BI in nascent HDL formation in primary hepatocytes isolated from mice deficient in ABCA1, ABCG1, or SR-BI and from wild-type (WT) mice. Under basal conditions, in WT hepatocytes, cholesterol efflux to exogenous apoA-I was accompanied by conversion of apoA-I to HDL-sized particles. LXR activation by T0901317 markedly enhanced the formation of larger HDL-sized particles as well as cellular cholesterol efflux to apoA-I. Glyburide treatment completely abolished the formation of 7.4 nm diameter and greater particles but led to the formation of novel 7.2 nm-sized particles. However, cells lacking ABCA1 failed to form such particles. ABCG1-deficient cells showed similar capacity to efflux cholesterol to apoA-I and to form nascent HDL particles compared with WT cells. Cholesterol efflux to apoA-I and nascent HDL formation were slightly but significantly enhanced in SR-BI-deficient cells compared with WT cells under basal but not LXR activated conditions. As in WT but not in ABCA1-deficient hepatocytes, 7.2 nm-sized particles generated by glyburide treatment were also detected in ABCG1-deficient and SR-BI-deficient hepatocytes. Our data indicate that hepatic nascent HDL formation is highly dependent on ABCA1 but not on ABCG1 or SR-BI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22190590      PMCID: PMC3276468          DOI: 10.1194/jlr.M017079

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  49 in total

1.  Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells.

Authors:  Menno Hoekstra; J Kar Kruijt; Miranda Van Eck; Theo J C Van Berkel
Journal:  J Biol Chem       Date:  2003-04-18       Impact factor: 5.157

2.  ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport.

Authors:  J Klucken; C Büchler; E Orsó; W E Kaminski; M Porsch-Ozcürümez; G Liebisch; M Kapinsky; W Diederich; W Drobnik; M Dean; R Allikmets; G Schmitz
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 3.  Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?

Authors:  Marina Cuchel; Daniel J Rader
Journal:  Circulation       Date:  2006-05-30       Impact factor: 29.690

4.  Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor.

Authors:  P Costet; Y Luo; N Wang; A R Tall
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

5.  Scavenger receptor-BI inhibits ATP-binding cassette transporter 1- mediated cholesterol efflux in macrophages.

Authors:  W Chen; D L Silver; J D Smith; A R Tall
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

6.  ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR.

Authors:  K Schwartz; R M Lawn; D P Wade
Journal:  Biochem Biophys Res Commun       Date:  2000-08-11       Impact factor: 3.575

7.  ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages.

Authors:  J F Oram; R M Lawn; M R Garvin; D P Wade
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

8.  Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1.

Authors:  N Wang; D L Silver; P Costet; A R Tall
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

9.  The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and -independent pathways.

Authors:  Robert S Kiss; Dan C McManus; Vivian Franklin; Wei Ling Tan; Andrea McKenzie; Giovanna Chimini; Yves L Marcel
Journal:  J Biol Chem       Date:  2003-01-22       Impact factor: 5.157

10.  Lack of Abcg1 results in decreased plasma HDL cholesterol levels and increased biliary cholesterol secretion in mice fed a high cholesterol diet.

Authors:  Harmen Wiersma; Niels Nijstad; Jan Freark de Boer; Ruud Out; Wytse Hogewerf; Theo J Van Berkel; Folkert Kuipers; Uwe J F Tietge
Journal:  Atherosclerosis       Date:  2009-03-11       Impact factor: 5.162

View more
  30 in total

1.  High density lipoprotein protects against polymicrobe-induced sepsis in mice.

Authors:  Ling Guo; Junting Ai; Zhong Zheng; Deborah A Howatt; Alan Daugherty; Bin Huang; Xiang-An Li
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

2.  Evacetrapib reduces preβ-1 HDL in patients with atherosclerotic cardiovascular disease or diabetes.

Authors:  Yunqin Chen; Jibin Dong; Xiaojin Zhang; Xueying Chen; Li Wang; Haozhu Chen; Junbo Ge; Xian-Cheng Jiang
Journal:  Atherosclerosis       Date:  2019-04-14       Impact factor: 5.162

3.  Interleukin-32 promotes lipid accumulation through inhibition of cholesterol efflux.

Authors:  Zonglei Xu; Aizhi Dong; Zerui Feng; Jing Li
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

4.  Impact of individual acute phase serum amyloid A isoforms on HDL metabolism in mice.

Authors:  Myung-Hee Kim; Maria C de Beer; Joanne M Wroblewski; Richard J Charnigo; Ailing Ji; Nancy R Webb; Frederick C de Beer; Deneys R van der Westhuyzen
Journal:  J Lipid Res       Date:  2016-03-27       Impact factor: 5.922

5.  Serum amyloid A is not incorporated into HDL during HDL biogenesis.

Authors:  Ailing Ji; Xuebing Wang; Victoria P Noffsinger; Drew Jennings; Maria C de Beer; Frederick C de Beer; Lisa R Tannock; Nancy R Webb
Journal:  J Lipid Res       Date:  2020-01-08       Impact factor: 5.922

Review 6.  From High-Density Lipoprotein Cholesterol to Measurements of Function: Prospects for the Development of Tests for High-Density Lipoprotein Functionality in Cardiovascular Disease.

Authors:  Frank M Sacks; Majken K Jensen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-25       Impact factor: 8.311

7.  High-Density Lipoprotein Biogenesis: Defining the Domains Involved in Human Apolipoprotein A-I Lipidation.

Authors:  Ricquita D Pollard; Brian Fulp; Mary G Sorci-Thomas; Michael J Thomas
Journal:  Biochemistry       Date:  2016-08-23       Impact factor: 3.162

8.  MCP-1 impacts RCT by repressing ABCA1, ABCG1, and SR-BI through PI3K/Akt posttranslational regulation in HepG2 cells.

Authors:  Can-Xia Huang; Yu-Ling Zhang; Jing-Feng Wang; Jie-Yu Jiang; Jin-Lan Bao
Journal:  J Lipid Res       Date:  2013-02-12       Impact factor: 5.922

9.  Serum amyloid A3 is a high density lipoprotein-associated acute-phase protein.

Authors:  Lisa R Tannock; Maria C De Beer; Ailing Ji; Preetha Shridas; Victoria P Noffsinger; Laura den Hartigh; Alan Chait; Frederick C De Beer; Nancy R Webb
Journal:  J Lipid Res       Date:  2017-12-15       Impact factor: 5.922

10.  Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans.

Authors:  Carlos O Mendivil; Jeremy Furtado; Allyson M Morton; Liyun Wang; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-11-05       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.